Fig. 2
From: CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
The relationship between clinical parameters and CD44 and the survival curve to evaluate the prognostic value of CD44. A CCK8 analysis showed that CD44 knockdown inhibited the proliferation rate of SGC7901 and MGC803 cells (*P < 0.05). B The wound healing test showed the migration ability of SGC7901 and MGC803 cells in the case of CD44 knockdown. C CD44 expression was evaluated in patient groups with different clinical parameters using the UALCAN database. From left to right, sex, tumour stage, and lymph node metastasis are shown. *P < 0.05, **P < 0.01, ****P < 0.0001. D The KM-Plotter database was used to demonstrate the impact of high CD44 expression on the survival and prognosis of OS, PFS and PPS in gastric cancer patients